The interest in gene therapy and production of vaccines based on plasmid DNA (pDNA) 
Introduction
Gene therapy and DNA-based vaccines for the cure and prevention of various diseases are among the most promising advances made in biotechnology in recent years. Both methods are based on the same principles, the introduction of genes that encode for an absent or defective protein (in the case of gene therapy) or for an antigen protein (in the case of DNA vaccines) into human cells (4, 15) .
Although currently only a few DNA vaccine products have gained market approval for veterinary applications, numerous clinical trials in humans are still being performed. Clinical progress in the field of DNA vaccination and gene therapy has led to an increased demand for pharmaceutical-grade plasmid DNA (pDNA), manufactured in compliance with the current Good Manufacturing Practices (cGMP) (23) .
Economical and effective production and purification processes are fundamental to produce pure pDNA at a large scale (17, 18) . A few years ago, the expectations of yearly plasmid production were grams, whereas today kilograms, or even tons, are considered possible (17) .
As a consequence of intensive process development and engineering, a number of pDNA manufacturing procedures have been developed and applied (1, 14) . This is also shown by the number of recent patents and patent applications in the field of plasmid upstream and downstream processing (2, 21).
There are many laboratory protocols for the production of pDNA that involve the use of solvents, toxic agents or enzymes (7, 8) . The RNase-A enzyme, typically prepared from bovine pancreas, is useful for eliminating RNA molecules but is not approved for the manufacture of pharmaceutical-grade pDNA (5, 19) .
The plasmid production process typically consists of four stages: fermentation, primary recovery, intermediate recovery, and purification. During fermentation, the cell harboring the plasmid is propagated. The cells are then harvested and disrupted during the primary recovery stage in order to obtain a clarified lysate containing the plasmid.
In the primary recovery stage cells are harvested from the fermentation broth and plasmid DNA is released from the cells along with other impurities. A significant reduction in volume occurs and the majority of the impurities such as extracellular liquid, proteins, genomic DNA (gDNA) and lipids are partially removed. The intermediate recovery stages are designed to further concentrate and purify the product (16) .
The reduction in volume is usually accompanied by precipitation, by using agents such as isopropanol (3, 7, 8) or polyethylene glycol (PEG) (10, 22) . Scalable techniques, like tangential flow ultrafiltration (TFUF) (20) , can also be used to desalinate and reduce the volume (6, 16) . TFUF using a polysulfone membrane with a cut size of 500 kDa and 1000 kDa has been reported to remove more than 90 % of the RNA and 95 % of the protein of clarified lysates, using CaCl 2 (6, 12) . However, for a particular process development, the size of the plasmid must be taken into account for selecting the membrane, and it is advisable to avoid the use of precipitating agents. In this work, the behavior of the tangential flow ultrafiltration (TFUF) operation in the intermediate recovery of plasmid pVAX1-LipL32 from E. coli ferments was investigated, with the aim to concentrate the plasmid and to remove impurities (RNA, proteins), avoiding the use of additional chemical agents. The experimental behavior was modeled to obtain a straightforward method to scale up the process.
Materials and Methods
Experimental setup the E. coli DH5α strain harboring the pVAX1-LipL32 plasmid with a length of 3819 base pairs (bp) was propagated overnight in a 2.0 L shake flask containing 250 mL of LB media at 37 °C and 260 r/min. The primary recovery of plasmid was carried out by cell harvest, lysis and clarification procedures (3, 11, 13) . Briefly, cell harvesting was performed by centrifugation at 5 000 g, 4 °C for 20 min. The pellet was resuspended in a buffer solution (25 mmol/l tris, 10 mmol/l eDtA and 50 mmol/l glucose, pH 8.0, at a ratio of 32 μL buffer/mL of culture), then an equal volume of lysis buffer was added (0.2 mol/L NaOH and 1 % SDS) .The resultant solution was incubated for 10 min at room temperature. Finally, the cell debris, proteins and genomic DNA (gDNA) were precipitated with an equal volume of pre-chilled 3.0 mol/L potassium acetate solution at pH 5.0, gently stirred and incubated on ice for 10 min. The alkaline lysate was clarified by eliminating the precipitate formed by centrifugation at 12 000 g for 30 min at 4 °C in two steps. The supernatant was diluted with 10 mmol/L Tris buffer and 1 mmol/L EDTA/HCl, pH 8.0 (TE buffer) in a 1:2 ratio and passed through a vacuum filter of 0.45 μm to remove the suspended particles remaining and to obtain the clarified lysate that was processed in the next step.
The intermediate recovery of plasmid was carried out in a tangential flow ultrafiltration unit consisting of a MidJet Benchtop System connected to a hollow fiber cartridge (GE Healthcare). The cartridge has two hollow fiber membranes of polysulfone, each 1.0 mm in inner diameter and 30 cm in length, giving a total filtration area of 16 cm 2 . Hollow fibers with 300 kDa or 500 kDa nominal molecular weight limit (NMWL) were used to conduct the experiments.
The system was operated in a diafiltration mode with a feed flow rate of 50 mL/min of clarified lysate (the initial transmembrane pressure according to the manufacturer was 1.5 psi). The wash solution used was TE buffer. The system was chosen in order to recover the plasmid and simultaneously remove the protein, RnA and to desalt the solution. the operation was conducted at a constant flux of 0.075 mL/ (cm 2 ·min) for the 300 kDa TFUF system and 0.113 mL/ (cm 2 ·min) for the 500 kDa TFUF system, using a check valve. The performance was determined by monitoring the absorbance at 260 nm and the conductivity of the retentate and the filtrate solution. TFUF was performed using 65 mL of clarified lysate with 2.0 absorbance units (AU) and 45.1 mS/cm conductivity. Washing was done with TE buffer at a flow rate of 1 mL/min, to desalt the solution. The filtered solution had an absorbance of 0.64 AU and a conductivity of 1.6 mS/cm.
Plasmid integrity
To verify the integrity of the pDNA, samples of filtrate and retentate were collected during the experiment, and analyzed by horizontal electrophoresis in agarose gel at 0.8 %. The buffer solution was 40 mmol/L Tris, 20 mmol/L acetic acid and 1 mmol/L EDTA at pH 8 (TAE buffer) and a Supercoiled Ladder DNA was used as a molecular weight marker. The gels were run for 3 h at 60 V, and stained with ethidium bromide (0.5 µg/mL).
Theory
Physical model. Fig. 1 shows a simplified diagram of the system for tangential flow ultrafiltration. The clarified lysate solution in the tank, with a nucleic acid concentration C A and volume V, was fed to the ultrafiltration membrane by a peristaltic pump at a constant flow of 50 mL/min. The operation was performed in diafiltration mode by continuously adding a volume V D of TE buffer, keeping the volume of tank V, constant. The filtrate with concentration C F was eliminated in a volume V F at a flow rate F. System model. A mass balance in the system defined by the dotted area in Fig. 1 was performed to describe the behavior of the system:
The filtrate volume V F is replaced by a washing volume V D , so Equation 1 can be expressed as:
A global retention coefficient, σ, for the system was used, that can be expressed as:
It was experimentally observed that the global retention coefficient varies with the operation time and can be expressed in terms of the washing volume V D , by using the following the model:
where s max is the maximum retention coefficient in the system, and k is the value of V D when s = s max /2. By combining Equations 2, 3 and 4, and integrating with the initial operating conditions, at t = 0: V D = 0 and C A = C A0 , we obtain:
Equations 3, 4 and 5 represent the model that describes the behavior of the tangential flow ultrafiltration used in the investigation.
Results and Discussion
The experimental global retention coefficient was calculated from Equation 3, using the absorbance data for the retentate and the filtrate measured at different times. To associate each measurement with the washing volume, V D , the filtrate volume V F was considered equal to V D , and calculated based on the average filtrate flow F.
the parameters s max and k from Equation 4 were calculated with experimental data, by means of a nonlinear regression. Fig. 2a and Fig. 2b show the retention coefficient values and the corresponding fitted curve, using Equation 4 for TFUF with 300 kDa and 500 kDa membranes, respectively. A good agreement between experimental and fitted values was observed. The adjusted parameters of the model were s max = 1.0 and k = 36.0 mL for the 300 kDa system and s max = 1.0 and k = 15.0 mL for the 500 kDa system.
The model given in Equation 5 was fitted to the retentate experimental values, using the corresponding s max and k parameters. the continuous line in Fig. 3 shows a good fit of the model to the dimensionless concentration of the retentate solution. Approximately 50 % of the contaminants were removed with 100 mL of washing buffer in the 300 kDa membrane system, whereas to attain the same purification in the 500 kDa membrane system, 210 mL were needed. The electrophoresis analysis showed that no plasmid was detected in the filtrate solution in the 300 kDa system, while in the 500 kDa system, a small amount of plasmid was detected. This phenomenon seems to be analogous to the observation that ultrafiltration membranes are often preferred over microfiltration membranes for cell retention of bacterial cells due to the reduced plugging of the pores that result in higher steady-state permeate fluxes (9) . In this case, the plasmid molecule appears to cause a plugging problem. These observations are consistent with the experimental behavior of the retention factor (Fig. 2) . It can be observed that approximately 80 % of the molecules smaller than 300 kDa (Fig. 4a) and smaller than 500 kDa (Fig. 4b) were filtered after washing with 100 mL of buffer. The figure also shows a good agreement between the model fitted using Equation 3 and the experimental data. The electrophoretic analysis of the samples collected during the experiments is shown in Fig. 5. Fig. 5a illustrates the reduction of contaminants in the retentate (lanes 5, 7, 9, 11) and the presence of low weight RNA in the filtrate (lanes 6, 8, 10, 12) as TFUF takes place in the 300 kDa system. Furthermore, no loss of plasmid through the pores of the membrane is observed. 8, 10, 12 ) and a greater presence of RNA in the filtrate (lanes 5, 7, 9, 11) as TFUF takes place in the 500 kDa system. However, some loss of plasmid through the pores of the membrane during the initial filtration period was detected (lanes 5, 7). this may have occurred previously to the plugging phenomena. In this operation, a good quality of the plasmid in the retentate and a substantial removal of RNA (lane 12) are observed.
Conclusions
Intermediate recovery of plasmid pVAX1-LipL32 from fermentation lysates of E.coli by diafiltration in a TFUF system using membranes of 300 kDa and 500 kDa NMWL was achieved. More than 50 % of the contaminants, particularly RNA, were removed by both systems. A good quality of the supercoiled plasmid was maintained through the process. The TFUF system can be efficiently used to recover plasmid molecules; moreover, it does not have an adverse environmental impact, since the operation does not use chemicals or produce waste. The approach used in this investigation can easily be applied to plasmid recovery in other types of lysates with other types of plasmids of different size or other macromolecules. Based on a parameter estimation study of the global retention coefficient, a simple mathematical model was obtained to describe the process behavior. This model can be used as a straightforward method to scale-up plasmid TFUF, when the flux and the composition of the lysate is maintained constant between the scales.
